Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Rheumatoid Arthritis

  Free Subscription


2 Ann Rheum Dis
2 Arthritis Res Ther
7 Clin Rheumatol
1 PLoS One
2 Rheumatol Int

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Rheum Dis

  1. BURMESTER GR, Gottenberg JE, Caporali R, Winthrop KL, et al
    Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years.
    Ann Rheum Dis. 2024 May 23:ard-2024-225759. doi: 10.1136/ard-2024-225759.
    PubMed         Abstract available

  2. LAGE-HANSEN PR, Svendsen N, Kirkham J, Nielsen SM, et al
    Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set.
    Ann Rheum Dis. 2024 May 22:ard-2024-225523. doi: 10.1136/ard-2024-225523.
    PubMed         Abstract available

    Arthritis Res Ther

  3. QIAN H, Deng C, Chen S, Zhang X, et al
    Targeting pathogenic fibroblast-like synoviocyte subsets in rheumatoid arthritis.
    Arthritis Res Ther. 2024;26:103.
    PubMed         Abstract available

  4. CHEN Z, Li X, Shi H, Huang Y, et al
    Causal relationship between rheumatoid arthritis and bronchiectasis: a bidirectional mendelian randomization study.
    Arthritis Res Ther. 2024;26:104.
    PubMed         Abstract available

    Clin Rheumatol

  5. CHEN G, Chen H, Wang Z, Cai H, et al
    Letter to the editor: "Definition of follicular helper T cell and cytokines expression in synovial fluid of rheumatoid arthritis".
    Clin Rheumatol. 2024 May 18. doi: 10.1007/s10067-024-07006.

  6. OPDAM MAA, Broeder ND, van den Bemt BJF, Mulder K, et al
    Higher infection risk for JAK inhibitors tofacitinib and baricitinib compared to subcutaneous biological DMARDs.
    Clin Rheumatol. 2024;43:2133-2138.
    PubMed         Abstract available

  7. SARIYILDIZ A, Coskun Benlidayi I, Yetisir A, Turk I, et al
    Central sensitization significantly deteriorates functionality and the interpretation of self-reported disease activity in primary Sjogren's syndrome.
    Clin Rheumatol. 2024;43:1949-1958.
    PubMed         Abstract available

  8. GOLOVINA OA, Torgashina AV, Gorodetskiy VR, Sockol EV, et al
    Combination of Sjogren's syndrome and anti-Ku syndrome complicated by the development of mucosa-associated lymphoid tissue lymphoma: case review and systematic review of the literature.
    Clin Rheumatol. 2024;43:2145-2152.
    PubMed         Abstract available

  9. LIU H, Yuan J, Tan X, Song W, et al
    Male patients with primary Sjogren's syndrome have unique clinical manifestations and circulating lymphocyte profiles.
    Clin Rheumatol. 2024;43:1927-1937.
    PubMed         Abstract available

  10. XIE Y, Fan Y, Su M, Wang Y, et al
    Characteristics of the oral microbiota in patients with primary Sjogren's syndrome.
    Clin Rheumatol. 2024;43:1939-1947.
    PubMed         Abstract available

  11. EL MIEDANY Y, El Gaafary M, Youssef S, El Aroussy N, et al
    Meaningful patient engagement in inflammatory arthritis: development of the Patient Motivation Questionnaire.
    Clin Rheumatol. 2024;43:1793-1801.
    PubMed         Abstract available

    PLoS One

  12. LIAO CS, He FZ, Li XY, Zhang Y, et al
    Analysis of common differential gene expression in synovial cells of osteoarthritis and rheumatoid arthritis.
    PLoS One. 2024;19:e0303506.
    PubMed         Abstract available

    Rheumatol Int

  13. SWEENEY M, Adas MA, Cope A, Norton S, et al
    Longitudinal effects of affective distress on disease outcomes in rheumatoid arthritis: a meta-analysis and systematic review.
    Rheumatol Int. 2024 May 22. doi: 10.1007/s00296-024-05574.
    PubMed         Abstract available

  14. PETZINNA SM, Winter L, Skowasch D, Pizarro C, et al
    Assessing sleep-related breathing disorders among newly diagnosed rheumatoid and psoriatic arthritis patients: a cross-sectional study.
    Rheumatol Int. 2024;44:1025-1034.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge.